Cresset Asset Management, LLC Frequency Therapeutics, Inc. Transaction History

Cresset Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$1.7 - $5.72 $12,750 - $42,900	7,500 Added 25.0%	37,500 $80,000
Q4 2021 Feb 10, 2022	BUY	$4.95 - $7.11 $148,500 - $213,300	30,000 New	30,000 $154,000
Q2 2021 Aug 10, 2021	SELL	$8.05 - $11.61 $241,500 - $348,300	-30,000 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$7.99 - $55.01 $60,052 - $413,455	-7,516 Reduced 20.03%	30,000 $285,000
Q3 2020 Nov 13, 2020	BUY	$17.76 - $24.96 $18,132 - $25,484	1,021 Added 2.8%	37,516 $721,000
Q2 2020 Aug 04, 2020	BUY	$14.65 - $24.9 $534,651 - $908,725	36,495 New	36,495 $849,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.